Literature DB >> 29683921

Effects of Exercise on ASC Methylation and IL-1 Cytokines in Heart Failure.

Brittany Butts1, Javed Butler2, Sandra B Dunbar3, Elizabeth Corwin3, Rebecca A Gary3.   

Abstract

INTRODUCTION/
PURPOSE: Inflammation contributes to heart failure (HF) progression and the interleukin (IL)-1 cytokine IL-1β is implicated in this process. The adaptor protein apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is necessary for inflammasome activation of IL-1β. Lower ASC methylation is associated with worse outcomes in HF. The purpose of this study was to examine the effects of exercise on changes in ASC methylation and activation of the IL-1 family cytokine IL-1β in persons with HF.
METHODS: Participants (N = 54) were randomized to receive exercise intervention (n = 38) or attention control (n = 16) for 3 months. Percent methylation of the ASC gene, plasma IL-1β, and ASC mRNA and were obtained at baseline, 3 months, and 6 months.
RESULTS: ASC methylation was higher in the exercise group as compared to control at 3 months (6.10% ± 0.5% vs 5.80% ± 0.4%; P = 0.04) and 6 months (6.07 ± 0.4 vs 5.82 ± 0.4; P = 0.04). Plasma IL-1β was lower in the exercise group at 3 months (1.43 ± 0.5 pg·mL vs 2.09 ± 1.3 pg·mL; P = 0.02) and 6 months (1.49 ± 0.5 pg·mL vs 2.13 ± 1.4 pg·mL; P = 0.004). ASC mRNA expression was negatively associated with ASC methylation at baseline (r = -0.97, P = 0.001), 3 months (r = -0.90, P = 0.001), and 6 months (r = -0.81, P = 0.001). ASC mRNA was lower than baseline at 3 months (P = 0.004) and 6 months (P = 0.002) among those in the exercise group. ASC methylation was positively associated with 6-min walk test at baseline (r = 0.517, P < 0.001), 3 months (r = 0.464, P = 0.004), and 6 months (r = 497, P = 0.05).
CONCLUSIONS: Exercise was related to increased mean percent ASC methylation and decreased IL-1β and ASC mRNA gene expression in HF. Epigenetic regulation of ASC can be a biological mechanism by which exercise can promote better outcomes in HF.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29683921      PMCID: PMC6095733          DOI: 10.1249/MSS.0000000000001641

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure.

Authors:  Michael J Shoemaker; Amy B Curtis; Eric Vangsnes; Michael G Dickinson
Journal:  Cardiopulm Phys Ther J       Date:  2013-09

Review 3.  Exercise and inflammation-related epigenetic modifications: focus on DNA methylation.

Authors:  Steven Horsburgh; Paula Robson-Ansley; Rozanne Adams; Carine Smith
Journal:  Exerc Immunol Rev       Date:  2015       Impact factor: 6.308

Review 4.  Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Rong-Hui Tu; Zhi-Yu Zeng; Guo-Qiang Zhong; Wei-Feng Wu; Yun-Juan Lu; Zhan-Dong Bo; Yan He; Wei-Qiang Huang; Li-Mei Yao
Journal:  Eur J Heart Fail       Date:  2014-05-02       Impact factor: 15.534

5.  Determining the minimal clinically important difference for the six-minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome.

Authors:  Vincent Gremeaux; Odile Troisgros; Sylvie Benaïm; Armelle Hannequin; Yves Laurent; Jean-Marie Casillas; Charles Benaïm
Journal:  Arch Phys Med Rehabil       Date:  2011-04       Impact factor: 3.966

6.  Effect of exercise training on inflammation status among people with metabolic syndrome.

Authors:  Dorthe Stensvold; Stig Arild Slørdahl; Ulrik Wisløff
Journal:  Metab Syndr Relat Disord       Date:  2012-03-28       Impact factor: 1.894

7.  Changes in the leukocyte methylome and its effect on cardiovascular-related genes after exercise.

Authors:  Joshua Denham; Brendan J O'Brien; Francine Z Marques; Fadi J Charchar
Journal:  J Appl Physiol (1985)       Date:  2014-12-24

Review 8.  NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

Authors:  Jurg Tschopp; Kate Schroder
Journal:  Nat Rev Immunol       Date:  2010-02-19       Impact factor: 53.106

9.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

10.  Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Laura O'Brien; Carlo Marchetti; Ignacio M Seropian; Norbert F Voelkel; Benjamin W Van Tassell; Charles A Dinarello; Antonio Abbate
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-14       Impact factor: 4.733

View more
  10 in total

Review 1.  NLRP3 Inflammasome: a Novel Insight into Heart Failure.

Authors:  Yunjiao Wang; Yanyang Li; Wanqin Zhang; Zhuo Yuan; Shichao Lv; Junping Zhang
Journal:  J Cardiovasc Transl Res       Date:  2022-06-13       Impact factor: 4.132

Review 2.  Targeting the NLRP3 inflammasome in cardiovascular diseases.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Leo F Buckley; Nicola Potere; Marcello Di Nisio; Giuseppe Biondi-Zoccai; Benjamin W Van Tassell; Antonio Abbate
Journal:  Pharmacol Ther       Date:  2021-12-11       Impact factor: 13.400

3.  MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice.

Authors:  Menglong Wang; Mengmeng Zhao; Junping Yu; Yao Xu; Jishou Zhang; Jianfang Liu; Zihui Zheng; Jing Ye; Zhen Wang; Di Ye; Yongqi Feng; Shuwan Xu; Wei Pan; Cheng Wei; Jun Wan
Journal:  Front Cardiovasc Med       Date:  2022-05-12

4.  Midazolam impacts acetyl-And butyrylcholinesterase genes: An epigenetic explanation for postoperative delirium?

Authors:  Katharina Rump; Caroline Holtkamp; Lars Bergmann; Hartmuth Nowak; Matthias Unterberg; Jennifer Orlowski; Patrick Thon; Zainab Bazzi; Maha Bazzi; Michael Adamzik; Björn Koos; Tim Rahmel
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

Review 5.  NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases.

Authors:  Yucheng Wang; Xiaoxiao Liu; Hui Shi; Yong Yu; Ying Yu; Minghui Li; Ruizhen Chen
Journal:  Clin Transl Med       Date:  2020-04-09

Review 6.  Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition.

Authors:  Omar Ramos-Lopez; Fermin I Milagro; Jose I Riezu-Boj; J Alfredo Martinez
Journal:  Inflamm Res       Date:  2020-11-24       Impact factor: 4.575

Review 7.  Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients.

Authors:  Lealem Gedefaw; Sami Ullah; Polly H M Leung; Yin Cai; Shea-Ping Yip; Chien-Ling Huang
Journal:  Cells       Date:  2021-04-16       Impact factor: 6.600

Review 8.  Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results.

Authors:  Timea Magdolna Szabo; Attila Frigy; Előd Ernő Nagy
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

Review 9.  Targeting Epigenetic Mechanisms in Vascular Aging.

Authors:  Zhongxiao Lin; Qian Ding; Xinzhi Li; Yuliang Feng; Hao He; Chuoji Huang; YiZhun Zhu
Journal:  Front Cardiovasc Med       Date:  2022-01-04

Review 10.  The epigenetic landscape of exercise in cardiac health and disease.

Authors:  Guiling Wu; Xing Zhang; Feng Gao
Journal:  J Sport Health Sci       Date:  2020-12-14       Impact factor: 7.179

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.